RURAL SCREENING CENTRE FOR PELVIC INFLAMMATORY DISEASE AND ITS EFFECTIVE MANAGEMENT WITH AYURVEDIC FORMULATIONS

"RURAL SCREENING CENTRE FOR PELVIC INFLAMMATORY DISEASE AND ITS EFFECTIVE MANAGEMENT WITH AYURVEDIC FORMULATIONS" - PID

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009820

Enrollment

100

Registered

2017-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnostic cases of PID

Interventions

Intervention1: Dashamoola quatha choorna lodhradi kalka pichu Brihatyadi kashaya Shigruvadi Guggulu Pushyanugaadi Choorna : 1.Local treatment of Yoni parisheka with dashamulakashaya and Yoni kalkadhar

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women in their 20-50yrs age group 2.Patients presenting with symptoms of vaginitis, cervicitis, endometritis and oophoritis 3.Patients presenting with mucopurulent per vaginal discharges 4.Diagnosed cases of chronic P.I.D. 5. Patients presenting with irregular menstruation and spotting due to P.I.D Patients presenting with deep seated dyspareunia ,post coital pain or discomfort due to P.I.D 6. Patients with tubo-ovarian mass of inflammatory origin 7. Cervical erosion, nebothian cysts, CIN Grade I & II 8. Borderline hypertensive patients are included

Exclusion criteria

Exclusion criteria: 1.Patients with CIN Grade III, STDs, Malignancy 2.Patients with Copper T in situ 3.Women with Pregnancy 4.P.I.D complicated with DM/moderate to severe HTN/ TB 5.Patients with acute P.I.D and peritonitis 6.P.I.D associated with prolapsed uterus 7.Patients with endometriosis/chocolate cyst/cervical polyp/ 8.Patients with exclusively vulvitis and bartholinitis 9.P.I.D associated with senility and menopause. 10.Patients who require surgical interventions in cases like pelvic abscess

Design outcomes

Primary

Measure	Time frame
1. study the impact of the Ayurvedic combination on the vaginal pathological microbial load and swab culture. 2. see the efficacy of the drug in restoring the fertility of the eligible couples after the subsidence of the disease. 3. screen the female patients of reproductive age group at SDM Hospital of Ayurveda for the detection of pelvic inflammatory disease (PID). study the efficacy of the selected drug combination in the management of PID.Timepoint: 45 days	—

Measure

Time frame

1. study the impact of the Ayurvedic combination on the vaginal pathological microbial load and swab culture. 2. see the efficacy of the drug in restoring the fertility of the eligible couples after the subsidence of the disease. 3. screen the female patients of reproductive age group at SDM Hospital of Ayurveda for the detection of pelvic inflammatory disease (PID). study the efficacy of the selected drug combination in the management of PID.Timepoint: 45 days

—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Mamatha

SDM College of Ayurveda and Hospital Kuthpady

mamath2@gmail.com08202520332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026